MRI-suspected low-grade glioma: Is there a need to perform dynamic FET PET?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 6, 2012, Pages 1021-1029

  Jansen, Nathalie L ^a   Graute, Vera ^a   Armbruster, Lena ^a   Suchorska, Bogdana ^a   Lutz, Juergen ^a   Eigenbrod, Sabina ^a   Cumming, Paul ^a   Bartenstein, Peter ^a   Tonn, Jörg Christian ^a   Kreth, Friedrich Wilhelm ^a   La Fougère, Christian ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

FET PET; Kinetic analysis; Non contrast enhancing brain lesions; Non invasive grading

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; DIAGNOSTIC ACCURACY; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KINETICS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; TUMOR VOLUME;

BIOLOGICAL TRANSPORT; COHORT STUDIES; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TYROSINE;

EID: 84862642880     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2109-9     Document Type: Article

References (46)

1. LE Ginsberg GN Fuller M Hashmi NE Leeds DF Schomer 1998 The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series Surg Neurol 49 436 440 9537664 10.1016/S0090-3019(97)00360-1 1:STN:280:DyaK1c7pslSitg%3D%3D
2. D Kondziolka LD Lunsford AJ Martinez 1993 Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma J Neurosurg 79 533 536 8410222 10.3171/jns.1993.79.4.0533 1:STN:280:DyaK2c%2FhsFemtw%3D%3D
3. JN Scott PM Brasher RJ Sevick NB Rewcastle PA Forsyth 2002 How often are nonenhancing supratentorial gliomas malignant? A population study Neurology 59 947 949 12297589 1:STN:280:DC%2BD38vovVWlsQ%3D%3D
4. FG Barker 2nd SM Chang SL Huhn RL Davis PH Gutin MW McDermott, et al. 1997 Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors Cancer 80 936 941 9307194 10.1002/(SICI)1097- 0142(19970901)80:5<936::AID-CNCR15>3.0.CO;2-X
5. G Popperl C Gotz W Rachinger FJ Gildehaus JC Tonn K Tatsch 2004 Value of O-(2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma Eur J Nucl Med Mol Imaging 31 1464 1470 15248032 10.1007/s00259-004-1590-1
6. W Rachinger C Goetz G Popperl FJ Gildehaus FW Kreth M Holtmannspotter, et al. 2005 Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas Neurosurgery 57 505 511 16145529 10.1227/01.NEU.0000171642.49553.B0
7. G Popperl R Goldbrunner FJ Gildehaus FW Kreth P Tanner M Holtmannspotter, et al. 2005 O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma Eur J Nucl Med Mol Imaging 32 1018 1025 15877226 10.1007/s00259-005-1819-7 1:STN:280:DC%2BD2MvpsVWhsQ%3D%3D
8. M Niyazi J Geisler A Siefert SB Schwarz U Ganswindt S Garny, et al. 2011 FET-PET for malignant glioma treatment planning Radiother Oncol 99 44 48 21458093 10.1016/j.radonc.2011.03.001
9. G Popperl FW Kreth J Herms W Koch JH Mehrkens FJ Gildehaus, et al. 2006 Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J Nucl Med 47 393 403 16513607
10. G Popperl FW Kreth JH Mehrkens J Herms K Seelos W Koch, et al. 2007 FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading Eur J Nucl Med Mol Imaging 34 1933 1942 17763848 10.1007/s00259-007-0534-y
11. M Weckesser KJ Langen CH Rickert S Kloska R Straeter K Hamacher, et al. 2005 O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours Eur J Nucl Med Mol Imaging 32 422 429 15650870 10.1007/s00259-004-1705-8 1:STN:280:DC%2BD2M7osleiuw%3D%3D
12. M Kunz N Thon S Eigenbrod C Hartmann R Egensperger J Herms, et al. 2011 Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas Neuro Oncol 13 307 316 21292686 10.1093/neuonc/noq196 1:STN:280:DC%2BC3M3gsl2msA%3D%3D
13. DJ Coope J Cizek C Eggers S Vollmar WD Heiss K Herholz 2007 Evaluation of primary brain tumors using 11C-methionine PET with reference to a normal methionine uptake map J Nucl Med 48 1971 1980 18006617 10.2967/jnumed.107.043240 1:CAS:528:DC%2BD1cXnvFSnsQ%3D%3D
14. FW Floeth D Pauleit HJ Wittsack KJ Langen G Reifenberger K Hamacher, et al. 2005 Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy J Neurosurg 102 318 327 15739561 10.3171/jns.2005.102.2.0318
15. K Herholz T Holzer B Bauer R Schroder J Voges RI Ernestus, et al. 1998 11C-methionine PET for differential diagnosis of low-grade gliomas Neurology 50 1316 1322 9595980 1:STN:280:DyaK1c3lsFCiuw%3D%3D
16. LW Kracht H Miletic S Busch AH Jacobs J Voges M Hoevels, et al. 2004 Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology Clin Cancer Res 10 7163 7170 15534088 10.1158/1078-0432.CCR-04-0262 1:CAS:528:DC%2BD2cXpsVKltLY%3D
17. D Pauleit F Floeth K Hamacher MJ Riemenschneider G Reifenberger HW Muller, et al. 2005 O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas Brain 128 678 687 15689365 10.1093/brain/awh399
18. F Stockhammer M Misch P Horn A Koch N Fonyuy M Plotkin 2009 Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas Acta Neurochir (Wien) 151 1377 1383 10.1007/s00701-009- 0462-7
19. F Thiele J Ehmer MD Piroth MJ Eble HH Coenen HJ Kaiser, et al. 2009 The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastoma Phys Med Biol 54 5525 5539 19717889 10.1088/0031-9155/54/18/012
20. RT Ullrich L Kracht A Brunn K Herholz P Frommolt H Miletic, et al. 2009 Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma J Nucl Med 50 1962 1968 19910435 10.2967/jnumed.109.065904
21. H Vees S Senthamizhchelvan R Miralbell DC Weber O Ratib H Zaidi 2009 Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients Eur J Nucl Med Mol Imaging 36 182 193 18818918 10.1007/s00259-008-0943-6
22. WA Weber HJ Wester AL Grosu M Herz B Dzewas HJ Feldmann, et al. 2000 O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study Eur J Nucl Med 27 542 549 10853810 10.1007/s002590050541 1:CAS:528:DC%2BD3cXis1Oqtrw%3D
23. C la Fougere B Suchorska P Bartenstein FW Kreth JC Tonn 2011 Molecular imaging of gliomas with PET: opportunities and limitations Neuro Oncol 13 806 819 21757446 10.1093/neuonc/nor054
24. B Langstrom H Lundqvist 1976 The preparation of 11C-methyl iodide and its use in the synthesis of 11C-methyl-L-methionine Int J Appl Radiat Isot 27 357 363 955739 10.1016/0020-708X(76)90088-0 1:CAS:528:DyaE28XlvVylsLY%3D
25. K Wienhard K Herholz HH Coenen J Rudolf P Kling G Stocklin, et al. 1991 Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine J Nucl Med 32 1338 1346 1906093 1:STN:280: DyaK3M3psVyrtg%3D%3D
26. HJ Wester M Herz W Weber P Heiss R Senekowitsch-Schmidtke M Schwaiger, et al. 1999 Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging J Nucl Med 40 205 212 9935078 1:CAS:528:DyaK1MXos1aitA%3D%3D
27. K Ishiwata K Kubota M Murakami R Kubota T Sasaki S Ishii, et al. 1993 Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissues be measured in vivo? J Nucl Med 34 1936 1943 8229238 1:CAS:528:DyaK2cXhvVKgsr8%3D
28. KJ Langen M Jarosch H Muhlensiepen K Hamacher S Broer P Jansen, et al. 2003 Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas Nucl Med Biol 30 501 508 12831987 10.1016/S0969-8051(03)00023-4 1:CAS:528: DC%2BD3sXkvVKhs78%3D
29. M Plotkin C Blechschmidt G Auf F Nyuyki L Geworski T Denecke, et al. 2010 Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas Eur Radiol 20 2496 2502 20521054 10.1007/s00330-010-1819-2
30. M Plotkin U Gneveckow K Meier-Hauff H Amthauer A Feussner T Denecke, et al. 2006 18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma Int J Hyperthermia 22 319 325 16754352 10.1080/02656730600734128 1:CAS:528:DC%2BD28XntlWhu70%3D
31. M Rickhey O Koelbl C Eilles L Bogner 2008 A biologically adapted dose-escalation approach, demonstrated for 18F-FET-PET in brain tumors Strahlenther Onkol 184 536 542 19016044 10.1007/s00066-008-1883-6
32. DC Weber T Zilli F Buchegger N Casanova G Haller M Rouzaud, et al. 2008 [(18)F]Fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma Radiat Oncol 3 44 19108742 10.1186/1748-717X-3-44
33. G Popperl C Gotz W Rachinger O Schnell FJ Gildehaus JC Tonn, et al. 2006 Serial O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma Eur J Nucl Med Mol Imaging 33 792 800 16550381 10.1007/s00259-005-0053-7
34. I Yang MK Aghi 2009 New advances that enable identification of glioblastoma recurrence Nat Rev Clin Oncol 6 648 657 19806145 10.1038/nrclinonc.2009.150
35. M Hutterer M Nowosielski D Putzer D Waitz G Tinkhauser H Kostron, et al. 2011 O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma J Nucl Med 52 856 864 21622893 10.2967/jnumed.110.086645 1:CAS:528:DC%2BC3MXot1yisLg%3D
36. FW Floeth D Pauleit M Sabel G Reifenberger G Stoffels W Stummer, et al. 2006 18F-FET PET differentiation of ring-enhancing brain lesions J Nucl Med 47 776 782 16644747 1:CAS:528:DC%2BD28XltFaiur0%3D
37. FW Floeth D Pauleit M Sabel G Stoffels G Reifenberger MJ Riemenschneider, et al. 2007 Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma J Nucl Med 48 519 527 17401087 10.2967/jnumed.106.037895 1:CAS:528:DC%2BD2sXhtVert7nM
38. FW Floeth M Sabel G Stoffels D Pauleit K Hamacher HJ Steiger, et al. 2008 Prognostic value of 18F-fluoroethyl-L-tyrosine PET and MRI in small nonspecific incidental brain lesions J Nucl Med 49 730 737 18413396 10.2967/jnumed.107. 050005
39. R Pichler A Dunzinger G Wurm J Pichler S Weis K Nussbaumer, et al. 2010 Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance? Eur J Nucl Med Mol Imaging 37 1521 1528 20396883 10.1007/s00259-010-1457-6
40. MV Padma S Said M Jacobs DR Hwang K Dunigan M Satter, et al. 2003 Prediction of pathology and survival by FDG PET in gliomas J Neurooncol 64 227 237 14558598 10.1023/A:1025665820001 1:STN:280:DC%2BD3svotVWgsQ%3D%3D
41. LW Kracht M Friese K Herholz R Schroeder B Bauer A Jacobs, et al. 2003 Methyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma Eur J Nucl Med Mol Imaging 30 868 873 12692687 10.1007/s00259-003-1148-7 1:CAS:528: DC%2BD3sXjvF2lsL0%3D
42. T Nojiri T Nariai M Aoyagi M Senda K Ishii K Ishiwata, et al. 2009 Contributions of biological tumor parameters to the incorporation rate of L-[methyl-(11)C]methionine into astrocytomas and oligodendrogliomas J Neurooncol 93 233 241 19099197 10.1007/s11060-008-9767-2 1:CAS:528:DC%2BD1MXlvFOms78%3D
43. AH Kaim B Weber MO Kurrer G Westera A Schweitzer J Gottschalk, et al. 2002 (18)F-FDG and (18)F-FET uptake in experimental soft tissue infection Eur J Nucl Med Mol Imaging 29 648 654 11976803 10.1007/s00259-002-0780-y 1:CAS:528:DC%2BD38XkvFSns7o%3D
44. FC Rau WA Weber HJ Wester M Herz I Becker A Kruger, et al. 2002 O-(2-[(18)F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes Eur J Nucl Med Mol Imaging 29 1039 1046 12173018 10.1007/s00259-002-0821-6 1:CAS:528:DC%2BD38Xls12gu7k%3D
45. D Salber G Stoffels D Pauleit G Reifenberger M Sabel NJ Shah, et al. 2006 Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemia Nucl Med Biol 33 1029 1035 17127177 10.1016/j.nucmedbio.2006.09.004 1:CAS:528:DC%2BD28Xht1Cls77K
46. D Salber G Stoffels D Pauleit AM Oros-Peusquens NJ Shah P Klauth, et al. 2007 Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses J Nucl Med 48 2056 2062 18006612 10.2967/jnumed.107.046615 1:CAS:528:DC%2BD1cXnvFSmug%3D%3D